This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1998 Mar 5;12(4):439-40.

Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection

E K Hester, J E Peacock Jr

PMID: 9520175

Case Reports

Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection

E K Hester et al. AIDS. 1998.

. 1998 Mar 5;12(4):439-40.

Authors

E K Hester, J E Peacock Jr

PMID: 9520175

No abstract available

PubMed Disclaimer

Similar articles

Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
Rabaud C, Bevilacqua S, Beguinot I, Dorvaux V, Schuhmacher H, May T, Canton P. Rabaud C, et al. Clin Infect Dis. 2001 May 15;32(10):1494-5. doi: 10.1086/320166. Epub 2001 Apr 18. Clin Infect Dis. 2001. PMID: 11317252
AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
[No authors listed] [No authors listed] AIDS. 2000 Mar 10;14(4):367-74. AIDS. 2000. PMID: 10770538 Clinical Trial.
Precipitous declines in hemoglobin levels associated with combination zidovudine and lamivudine therapy.
Tseng A, Conly J, Fletcher D, Keystone D, Salit I, Walmsley S. Tseng A, et al. Clin Infect Dis. 1998 Oct;27(4):908-9. doi: 10.1086/517169. Clin Infect Dis. 1998. PMID: 9798060 No abstract available.
New drug interactions with zidovudine.
Robertson-Dallas S, Read SE, Bendayan R. Robertson-Dallas S, et al. Pharmacotherapy. 1997 Nov-Dec;17(6):1198-209. Pharmacotherapy. 1997. PMID: 9399602 Review.
[Erythropoietin treatment of anemia associated with human immunodeficiency virus infection].
Moreno García M. Moreno García M. Med Clin (Barc). 1997 Feb 22;108(7):266-71. Med Clin (Barc). 1997. PMID: 9121196 Review. Spanish. No abstract available.

See all similar articles

Cited by

A case series of emtricitabine-induced pure red cell aplasia.
Manickchund N, du Plessis C, John MA, Manzini TC, Gosnell BI, Moosa MS. Manickchund N, et al. South Afr J HIV Med. 2021 Aug 30;22(1):1271. doi: 10.4102/sajhivmed.v22i1.1271. eCollection 2021. South Afr J HIV Med. 2021. PMID: 34522429 Free PMC article.
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.
Steele KT, Steenhoff AP, Newcomb CW, Rantleru T, Nthobatsang R, Lesetedi G, Bellamy SL, Nachega JB, Gross R, Bisson GP. Steele KT, et al. PLoS One. 2011;6(6):e20010. doi: 10.1371/journal.pone.0020010. Epub 2011 Jun 15. PLoS One. 2011. PMID: 21698283 Free PMC article.
Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, Moyo S, Makhema J, Essex M, Lockman S. Dryden-Peterson S, et al. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):428-36. doi: 10.1097/QAI.0b013e31820bd2b6. J Acquir Immune Defic Syndr. 2011. PMID: 21266910 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Medical
- Genetic Alliance
- MedlinePlus Health Information

-